IRAK Antibodies
Interleukin-1 receptor-associated kinase (IRAK) is a key signaling kinase involved in the Toll-like receptor (TLR) and interleukin-1 receptor (IL-1R) pathways, which are critical for innate immune responses. IRAK family proteins (IRAK1, IRAK2, IRAK3/IRAK-M, and IRAK4) play distinct roles in mediating the activation of nuclear factor kappa B (NF-κB), mitogen-activated protein kinases (MAPKs), and the production of pro-inflammatory cytokines. Dysregulation of IRAK activity has been implicated in inflammatory diseases, autoimmune disorders, and cancer, making IRAK antibodies essential for studying these signaling pathways in various biological contexts.
Content
IRAK antibodies are immunological reagents that target individual IRAK proteins, enabling their detection, quantification, and functional analysis in different experimental systems. Monoclonal IRAK antibodies, which bind to a single epitope, provide high specificity and reproducibility, making them ideal for precise applications. Polyclonal antibodies, which recognize multiple epitopes, offer increased sensitivity, particularly for detecting low-abundance IRAK proteins.
Applications of IRAK Antibody
- Innate Immune Response and Inflammation Research: IRAK proteins are critical mediators of innate immune responses triggered by TLR and IL-1R signaling. IRAK antibodies are used extensively in research focused on the immune system to study how IRAK proteins regulate inflammation. For example, IRAK1 and IRAK4 antibodies are used to monitor activation and phosphorylation status in response to pathogen-associated molecular patterns (PAMPs), such as lipopolysaccharide (LPS).
- Autoimmune and Inflammatory Disease Studies: Dysregulated IRAK signaling has been linked to the development of autoimmune and inflammatory diseases such as rheumatoid arthritis, systemic lupus erythematosus (SLE), and inflammatory bowel disease (IBD). IRAK antibodies are used to study the aberrant activation of IRAK proteins in these diseases.
- Cancer Research: IRAK signaling has been implicated in tumorigenesis, particularly in cancers associated with chronic inflammation, such as colorectal cancer, liver cancer, and hematologic malignancies. IRAK antibodies are used in cancer research to study how IRAK-driven inflammation contributes to cancer progression and metastasis.
IRAK antibodies are invaluable tools in studying the role of IRAK proteins in immune signaling, inflammation, autoimmune diseases, and cancer. These antibodies enable the precise detection, quantification, and functional analysis of IRAK family members in a variety of biological contexts.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|